Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens

Vaccine

Volumn 34, Issue 40, 2016, Pages 4807-4813

  Singh, Shirene M ^a   Alkie, Tamiru N ^a   Nagy, Éva ^a   Kulkarni, Raveendra R ^a   Hodgins, Douglas C ^a   Sharif, Shayan ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Avian influenza virus; Chickens; CpG ODN; Delivery system; Immune response; Nanoparticle; Poly(D,L lactic co glycolic acid)

Indexed keywords

AVIAN INFLUENZA VACCINE; CPG OLIGODEOXYNUCLEOTIDE; HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN Y; NANOCARRIER; POLYGLACTIN; CPG-OLIGONUCLEOTIDE; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; INFLUENZA VACCINE; LACTIC ACID; NANOPARTICLE; OLIGODEOXYRIBONUCLEOTIDE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; CHICKEN MODEL; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A VIRUS (H9N2); NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS NEUTRALIZATION; VIRUS SHEDDING; ANIMAL; AVIAN INFLUENZA; BIRD DISEASE; BLOOD; CHICKEN; IMMUNOLOGY; MUCOSAL IMMUNITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CHICKENS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; INFLUENZA A VIRUS, H9N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; LACTIC ACID; NANOPARTICLES; OLIGODEOXYRIBONUCLEOTIDES; POLYGLYCOLIC ACID; POULTRY DISEASES; VACCINES, INACTIVATED; VIRUS SHEDDING;

EID: 84995527940     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.08.009     Document Type: Article

References (43)

1. [1] Pasick, J., Berhane, Y., Hooper-McGrevy, K., Avian influenza: the Canadian experience. Rev Sci Tech Off Int Epiz 28 (2009), 349–358.
2. [2] Katz, J.M., Veguilla, V., Belser, J.A., Maines, T.R., Van Hoeven, N., Pappas, C., et al. The public health impact of avian influenza viruses. Poult Sci 88 (2009), 872–879.
3. [3] van den Berg, T., Lambrecht, B., Marché, S., Steensels, M., Van Borm, S., Influenza vaccines and vaccination strategies in birds. Comp Immunol Microbiol Infect Dis 31 (2008), 121–165.
4. [4] Wang, Y., Shan, C., Ming, S., Lui, Y., Du, Y., Jiang, G., Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res Vet Sci 86 (2009), 399–405.
5. [5] Fu, J., Liang, J., Kang, H., Lin, J., Yu, Q., Yang, Q., Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens. Poult Sci 92 (2013), 2866–2875.
6. [6] Hung, L.H., Tsai, P.C., Wang, C.H., Li, S.L., Huang, C.C., Lien, Y.Y., et al. Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian infuenza vaccine in chickens. Vaccine 29 (2011), 4668–4675.
7. [7] Swayne, D.E., Kapczynski, D., Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 225 (2008), 314–331.
8. [8] Gupta, S.K., Deb, R., Dey, S., Chellappa, M.M., Toll-like receptor-based adjuvants: enhancing the immune response to vaccines against infectious diseases of chicken. Expert Rev Vaccines 13 (2014), 909–925.
9. [9] Coffman, R.L., Sher, A., Seder, R.A., Vaccine adjuvants: putting innate immunity to work. Immunity 33 (2010), 492–503.
10. [10] St. Paul, M., Brisbin, J.T., Barjesteh, N., Villaneuva, A.I., Parvizi, P., Read, L.R., et al. Avian influenza virus vaccines containing toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens. Viral Immunol 27 (2014), 160–166.
11. [11] St Paul, M., Barjesteh, N., Brisbin, J.T., Villaneuva, A.I., Read, L.R., Hodgins, D., et al. Effects of ligands for toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens. Viral Immunol 27 (2014), 167–173.
12. [12] Singh, S.M., Alkie, T.N., Hodgins, D.C., Nagy, E., Shojadoost, B., Sharif, S., Systemic immune responses to an inactivated, whole H9N2 avian influenza virus vaccine using class B CpG oligonucleotides in chickens. Vaccine 33 (2015), 3947–3952.
13. [13] Zhao, L., Seth, A., Wibowo, N., Zhao, C., Mitter, N., Yu, C., et al. Nanoparticle vaccines. Vaccine 32 (2014), 327–337.
14. [14] Gregory, A.E., Titball, R., Williamson, D., Vaccine delivery using nanoparticles. Front Cell Infect Microbiol, 3, 2013, 13.
15. [15] Sharma, S., Hinds, L.A., Formulation and delivery of vaccines: ongoing challenges for animal management. J Pharm Bioall Sci 4 (2012), 258–266.
16. [16] Gerdts, V., Mutwiri, G.K., Tikoo, S.K., Babiuk, L.A., Mucosal delivery of vaccines in domestic animals. Vet Res 37 (2006), 487–510.
17. [17] Spickler, A.R., Roth, J.A., Adjuvants in veterinary vaccines: modes of action and adverse effects. J Vet Int Med 17 (2003), 273–281.
18. [18] Subbarao, K., Joseph, T., Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev Immunol 7 (2007), 267–278.
19. [19] Benne, C.A., Harmsen, M., van der Graaff, W., Verheul, A.F.M., Snippe, H., Kraaijeveld, C.A., Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants. Vaccine 15 (1997), 1039–1044.
20. [20] Kreijtz, J.H.C.M., Fouchier, R.A.M., Rimmelzwaan, G.F., Immune responses to influenza virus infection. Virus Res 162 (2011), 19–30.
21. [21] Chen, D., Periwal, S.B., Larrivee, K., Zuleger, C., Erickson, C.A., Endres, R.L., et al. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization. J Virol 75 (2001), 7956–7965.
22. [22] Olah, I., Kupper, A., Kittner, Z., The lymphoid substance of the chicken's harderian gland is organized in two histologically distinct compartments. Microsc Res Tech 34 (1996), 166–176.
23. [23] Jeurissen, S.H.M., Vervelde, L., Janse, E.M., Structure and function of lymphoid tissues of the chicken. Poult Sci Rev 5 (1994), 183–207.
24. [24] Scott, T.R., Savage, M.L., Olah, I., Plasma cells of the chicken Harderian gland. Poult Sci 72 (1993), 1273–1279.
25. [25] de Geus, E.D., Rebel, J.M.J., Vervelde, L., Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines. The Vet Quart 32 (2012), 75–86.
26. [26] Toro, H., Lavaud, P., Vallejos, P., Ferreira, A., Transfer of IgG from serum to lachrymal fluid in chickens. Avian Dis 37 (1993), 60–66.
27. [27] Szretter, K.J., Balish, A.L., Katz, J.M., Influenza: propagation, quantification, and storage. Grigg, M., McBride, A., Quarles, J., Stevenson, B., Taylor, R., (eds.) Current protocols in microbiology, 2005, John Wiley & Sons, Inc Unit 15G.1.
28. [28] Singh, S.M., Alkie, T.N., Abdelaziz, K.T., Hodgins, D.C., Novy, A., Nagy, E., et al. Viral Immunol 29 (2016), 269–275.
29. [29] Boussif, O., Lezoualc′h, F., Zanta, M.A., Mergny, M.D., Scherman, D., Demeneix, B., et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Nalt Acad Sci 92 (1995), 7297–7301.
30. [30] Peine, K.J., Bachelder, E.M., Vangundy, Z., Papenfuss, T., Brackman, D.J., Gallovic, M.D., et al. Efficient delivery of the toll-like receptor agonists polyinosinic: polycytidylic acid and CpG to macrophages by acetalated dextran microparticles. Mol Pharm 10 (2013), 2849–2857.
31. [31] Kulkarni, R.R., Rasheed, M.A., Bhaumik, S.K., Ranjan, P., Cao, W., Davis, C., et al. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity. J Virol 88 (2014), 13990–14001.
32. [32] Hodgins, D.C., Shewen, P.E., Vaccination of neonatal colostrum-deprived calves against Pasteurella haemolytica A1. Can J Vet Res 64 (2000), 3–8.
33. [33] Kasturi, S.P., Skountzou, I., Albrecht, R.A., Koutsonanos, D., Hua, T., Nakaya, H.I., et al. Programming the magnitude and persistence of antibody responses with innate immunity. Nature 470 (2011), 543–547.
34. [34] Wieland, W.H., Orzaez, D., Lammers, A., Parmentier, H.K., Verstegen, M.W., Schots, A., A functional polymeric immunoglobulin receptor in chickens (Gallus gallus) indicates ancient role of secretory IgA in mucosal immunity. Biochem J 380 (2004), 669–676.
35. [35] Mallick, A.I., Kulkarni, R.R., St Paul, M., Parvizi, P., Nagy, E., Behboudi, S., et al. Vaccination with CpG-adjuvanted avian influenza virosomes promotes antiviral immune responses and reduces virus shedding in chickens. Viral Immunol 25 (2012), 226–231.
36. [36] Feng, J., Gulati, U., Zhang, X., Keitel, W.A., Thompson, D.M., James, J.A., et al. Antibody quantity versus quality after influenza vaccination. Vaccine 27 (2009), 6358–6362.
37. [37] Bode, C., Zhao, G., Steinhagen, F., Kinjo, T., Klinman, D.M., CpG DNA as a vaccine adjuvant. Expert Rev Vaccines 10 (2011), 499–511.
38. [38] Schijns, V.E., Immunological concepts of vaccine adjuvant activity. Curr Opin Immunol 12 (2000), 456–463.
39. [39] Jiang, W., Gupta, R.K., Deshpande, M.C., Schwendeman, S.P., Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. Adv Drug Deliv Rev 57 (2005), 391–410.
40. [40] Jain, S., O'Hagan, D.T., Singh, M., The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant. Expert Rev Vaccines 10 (2011), 1731–1742.
41. [41] Chadwick, S., Kriegel, C., Amiji, M., Nanotechnology solutions for mucosal immunization. Adv Drug Deliv Rev 62 (2010), 394–407.
42. [42] Xiang, S.D., Scholzen, A., Minigo, G., David, C., Apostolopoulos, V., Mottram, P.L., et al. Pathogen recognition and development of particulate vaccines: does size matter?. Methods 40 (2006), 1–9.
43. [43] Oyewumi, M.O., Kumar, A., Cui, Z., Nano-microparticles as immunoadjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 9 (2010), 1095–1107.